Lindbrook Capital, LLC
- SEC CIK
- 0001767045
- Latest filing
- May 5, 2025
TARS holding history
Tarsus Pharmaceuticals, Inc. in every 13F filed by Lindbrook Capital, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
TARS overviewAll 13F holders of TARSFull Q1 2025 holdings
- Shares (Q1 2025)
- 117
- Value
- $6.01K
- % of portfolio
- <0.1%
- Quarters held
- 10
- Since Q2 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2025 | 117 | $6.01K | <0.1% | +7+6.4% | Added | Holders |
| Q4 2024 | 110 | $6.09K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 110 | $3.62K | <0.1% | −9−7.6% | Reduced | Holders |
| Q2 2024 | 119 | $3.23K | <0.1% | +25+26.6% | Added | Holders |
| Q1 2024 | 94 | $3.42K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 94 | $1.90K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 94 | $1.67K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 94 | $1.70K | <0.1% | +94 | New | Holders |
| Q4 2022 | 0 | $0 | 0.0% | −106−100.0% | Sold out | Holders |
| Q3 2022 | 106 | $2.00K | <0.1% | −11−9.4% | Reduced | Holders |
| Q2 2022 | 117 | $2.00K | <0.1% | +117 | New | Holders |